Appropriateness of Antibiotic use for the Management of Acute Diarrhea Among Under-Five Children Treated at Primary Care Centers in Northwest Ethiopia: A Cross-Sectional Study
Abstract:Background Acute diarrhea management is solely aimed at fluid replacement and nutritional support while antibiotics have a very limited role. Antibiotic treatment is recommended only for bloody diarrhea (dysentery), cholera and invasive bacterial diarrhea. This study is launched to assess the appropriateness of antibiotic use for the management of acute diarrhea among under-five children in Gondar town primary care centers.Methods Institutional based cross-sectional study was conducted in three primary care ce… Show more
“…Management of acute diarrhea focuses on uid replacement and nutritional support. According to the WHO guidelines, oral rehydration solution (ORS) with zinc is the rst-line treatment for acute diarrhea whereas antimicrobials are reserved for bloody diarrhea, cholera, and invasive bacterial diarrhea in children [7,9] . Most of the time, acute diarrheal disease is selflimiting and of viral origin, thus the use of antimicrobials is not recommended for mild or moderate and watery diarrhea.…”
Section: Introductionmentioning
confidence: 99%
“…In Ethiopia, diarrhea in children commonly gets treated empirically without identifying the real causative agent. Moreover, the cheap and wide availability of co-trimoxazole is enabling the irrational use of this medicine [9,15] . Co-trimoxazole resistance to the common bacterial enteropathogens of diarrhea has been reported with varying percentage prevalence.…”
Section: Introductionmentioning
confidence: 99%
“…The incidence of enteric bacterial resistance to commonly prescribed antimicrobials has remarkably increased [12] . Among the inappropriately prescribed (66.2%) antimicrobials for acute diarrhea in Ethiopian children, cotrimoxazole was the most inappropriately-prescribed medicine accounting for 63.6% followed by amoxicillin (2.6%) [9] . Co-trimoxazole was prescribed for the majority of the children (70.7%) who presented with diarrhea, whereas metronidazole (7%) and amoxicillin (4.6%) were less commonly prescribed drugs [15] .…”
Background: South Asia and Sub-Saharan Africa account for about 90% of all diarrheal fatalities in children worldwide. The World Health Organization guideline suggests the use of co-trimoxazole in the management of bloody diarrhea, cholera, and invasive bacterial diarrhea in children. However, there are reports on the inappropriate and empirical use of co-trimoxazole for the management of diarrhea in Ethiopia. Our objective was to estimate the prevalence of bacterial resistance against co-trimoxazole from stool isolates of diarrheic children in Ethiopia and to identify the factors associated with it.
Methods:We conducted a comprehensive database search in PubMed and Embase electronic databases to retrieve studies published between 2000 and 2021. We assessed heterogeneity across studies using Higgin's I² test statistic and Cochrane Q test. We used a random-effects model to pool the proportion of bacterial resistance. We evaluated publication bias using a funnel plot and Egger's regression test. The Joanna Briggs Institute (JBI) critical appraisal tool was used to measure the quality of the papers included.
Results: We included 20 eligible studies (1040 isolates) reporting the antimicrobial resistance of Shigella, Salmonella, E.coli,and Campylobacter against co-trimoxazole. The pooled proportion of co-trimoxazole resistance to the four diarrheagenic enteropathogens was 50.3 % with (95%CI: 41.7%-58.8%). We carried out a subgroup analysis based on four factors; bacterial species, participants’ age, region, study setting and sample size. The highest resistance was E. coli, 62.3 % (95%CI; 38%-83%) followed by Shigella 51.4% (95%CI; 38%-64%). There was a significant difference in the co-trimoxazole resistance of studies that had a sample size above 250 participants (58.5%) versus studies having a sample size below 250 (34.2%). However, there was no significant difference in co-trimoxazole resistance between children aged below 5 years compared with children above 5 years.
Conclusion: Bacterial isolates from the stool of diarrheic Ethiopian children have shown resistance to co-trimoxazole. E. coli showed the highest resistance among the isolates. Therefore, we need to exercise caution in the over-the-counter use of co-trimoxazole and promote the rational use and prescribing practice of co-trimoxazole by healthcare providers. Prevention interventions such as safe drinking water, improved sanitation, and handwashing with soap can reduce disease risk and the use of antibiotic use. Additionally, breastfeeding and rotavirus vaccination can also reduce the incidence of acute gastroenteritis in young children.
Systematic review registration PROSPERO CRD42023281838.
“…Management of acute diarrhea focuses on uid replacement and nutritional support. According to the WHO guidelines, oral rehydration solution (ORS) with zinc is the rst-line treatment for acute diarrhea whereas antimicrobials are reserved for bloody diarrhea, cholera, and invasive bacterial diarrhea in children [7,9] . Most of the time, acute diarrheal disease is selflimiting and of viral origin, thus the use of antimicrobials is not recommended for mild or moderate and watery diarrhea.…”
Section: Introductionmentioning
confidence: 99%
“…In Ethiopia, diarrhea in children commonly gets treated empirically without identifying the real causative agent. Moreover, the cheap and wide availability of co-trimoxazole is enabling the irrational use of this medicine [9,15] . Co-trimoxazole resistance to the common bacterial enteropathogens of diarrhea has been reported with varying percentage prevalence.…”
Section: Introductionmentioning
confidence: 99%
“…The incidence of enteric bacterial resistance to commonly prescribed antimicrobials has remarkably increased [12] . Among the inappropriately prescribed (66.2%) antimicrobials for acute diarrhea in Ethiopian children, cotrimoxazole was the most inappropriately-prescribed medicine accounting for 63.6% followed by amoxicillin (2.6%) [9] . Co-trimoxazole was prescribed for the majority of the children (70.7%) who presented with diarrhea, whereas metronidazole (7%) and amoxicillin (4.6%) were less commonly prescribed drugs [15] .…”
Background: South Asia and Sub-Saharan Africa account for about 90% of all diarrheal fatalities in children worldwide. The World Health Organization guideline suggests the use of co-trimoxazole in the management of bloody diarrhea, cholera, and invasive bacterial diarrhea in children. However, there are reports on the inappropriate and empirical use of co-trimoxazole for the management of diarrhea in Ethiopia. Our objective was to estimate the prevalence of bacterial resistance against co-trimoxazole from stool isolates of diarrheic children in Ethiopia and to identify the factors associated with it.
Methods:We conducted a comprehensive database search in PubMed and Embase electronic databases to retrieve studies published between 2000 and 2021. We assessed heterogeneity across studies using Higgin's I² test statistic and Cochrane Q test. We used a random-effects model to pool the proportion of bacterial resistance. We evaluated publication bias using a funnel plot and Egger's regression test. The Joanna Briggs Institute (JBI) critical appraisal tool was used to measure the quality of the papers included.
Results: We included 20 eligible studies (1040 isolates) reporting the antimicrobial resistance of Shigella, Salmonella, E.coli,and Campylobacter against co-trimoxazole. The pooled proportion of co-trimoxazole resistance to the four diarrheagenic enteropathogens was 50.3 % with (95%CI: 41.7%-58.8%). We carried out a subgroup analysis based on four factors; bacterial species, participants’ age, region, study setting and sample size. The highest resistance was E. coli, 62.3 % (95%CI; 38%-83%) followed by Shigella 51.4% (95%CI; 38%-64%). There was a significant difference in the co-trimoxazole resistance of studies that had a sample size above 250 participants (58.5%) versus studies having a sample size below 250 (34.2%). However, there was no significant difference in co-trimoxazole resistance between children aged below 5 years compared with children above 5 years.
Conclusion: Bacterial isolates from the stool of diarrheic Ethiopian children have shown resistance to co-trimoxazole. E. coli showed the highest resistance among the isolates. Therefore, we need to exercise caution in the over-the-counter use of co-trimoxazole and promote the rational use and prescribing practice of co-trimoxazole by healthcare providers. Prevention interventions such as safe drinking water, improved sanitation, and handwashing with soap can reduce disease risk and the use of antibiotic use. Additionally, breastfeeding and rotavirus vaccination can also reduce the incidence of acute gastroenteritis in young children.
Systematic review registration PROSPERO CRD42023281838.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.